Cytokinetics | CYTK - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Amgen USD 31.48B 2.42B 2026-03
Arca Biopharma USD 343.86M 11.31M 2025-12
Bayer EUR 32.91B 30M 2025-12
Biogen USD 9.19B 216.3M 2026-03
Brainstorm Cell Therapeutics USD 307K 201K 2025-12
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Capricor Therapeutics USD 322.94M 221.99M 2025-12
Cytokinetics USD 839.46M 77.51M 2026-03
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.44B 41.03M 2025-12
Geron USD 520.27M 2.07M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03